Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

ShORe Phase 3 topline results accelerated; trial did not meet primary endpoint of mean change in BCVA from baseline to week 52Opthea and DFA ...

Consortium and Electronic Clinical Outcome Assessment (eCOA) Consortium are pleased to announce the successful conclusion of the eCOA: Getting Better Together Initiative. This initiative, driven by a ...

Physician empathy is associated with greater patient satisfaction and outcomes, researchers found, according to a column ...

Longeveron (LGVN) announced the outcome of a Type B meeting with the U.S. Food and Drug Administration, supporting the advancement of ...

When combined with clinical variables, these features demonstrated high predictive power for both PD-L1 levels and immunotherapy outcomes. This study was approved by the Institutional Review Boards of ...

lumc.nl Background In The Netherlands, health professionals have created a doctor-driven standardised system to report and analyse adverse outcomes (AO ... AO reporting that is integrated into routine ...